Back to top
more

CVS Health (CVS)

(Real Time Quote from BATS)

$57.31 USD

57.31
6,697,092

-0.31 (-0.54%)

Updated Jul 10, 2024 03:32 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 1% (247 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Arpita Dutt headshot

Is a CVS Health (CVS) - Aetna (AET) Deal in the Cards?

by Arpita Dutt

Is an e-commerce company's interest in entering the drug pharmacy space the reason behind CVS Health's (CVS) interest in acquiring Aetna?

    Rite Aid (RAD) Slumps 14% Since Q2 Loss: What Lies Ahead?

    by Zacks Equity Research

    Rite Aid Corporation (RAD), which had quite an eventful journey of late, reported dismal second-quarter fiscal 2018 results last week. However, latest deal with Walgreens should benefit.

      Can Fred's Strategies Help It Counter Slow Comps & Traffic?

      by Zacks Equity Research

      Fred's (FRED) has been struggling with declining store traffic and sluggish comps over the past few quarters. The company has been focusing on cost reduction and internal restructuring.

        What FTC's Curtail on RAD Store Purchase Means for Walgreens?

        by Zacks Equity Research

        Walgreens' (WBA) purchase of lesser number of Rite Aid stores upsets investors. Let's draw an insight from this.

          Rite Aid Gets FTC Nod for Sale of Fewer Stores to Walgreens

          by Zacks Equity Research

          After four amendments, Rite Aid Corp. (RAD) and Walgreens Boots Alliance Inc. (WBA) finally received a nod for the fresh proposal the latter put forward yesterday.

            Ryan McQueeney headshot

            Why Did Rite Aid (RAD) Stock Crash Today?

            by Ryan McQueeney

            Shares of Rite Aid (RAD) fell more than 10% on Tuesday after Walgreens Boots (WBA) received government approval to buy fewer Rite Aid stores than had initially been proposed.

              Walgreens to Revisit Rite Aid Deal for Antitrust Approval

              by Zacks Equity Research

              The Federal Trade Commission ("FTC") seems to be getting harsher on drugstore chains Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. (RAD), which have been trying to appease the regulatory body since its initial merger pact in 2015.

                The Zacks Analyst Blog Highlights: Disney, Kraft Heinz and CVS Health, Intercontinental Exchange and Ventas

                by Zacks Equity Research

                The Zacks Analyst Blog Highlights: Disney, Kraft Heinz and CVS Health, Intercontinental Exchange and Ventas

                  Tobacco Stocks in Focus as Cigarette Prices Rise in New York

                  by Zacks Equity Research

                  The news of cigarette price hike in New York City and other legislations to reduce the number of smokers have raised concerns of accelerated sales declines for traditional cigarettes.

                    What You Should Know About Fred's Apart From Dismal Comps

                    by Zacks Equity Research

                    Fred's (FRED) is yet to recover from the cancelled Walgreens-Rite Aid merger. The company has also been struggling with declining sales owing to lower comps and store closures.

                      Investors Are Keeping An Eye On Q2 Earnings

                      by Zacks Equity Research

                      Investors Are Keeping An Eye On Q2 Earnings

                        Mark Vickery headshot

                        Q2 Earnings Rundown: KORS, RL, CVS & More

                        by Mark Vickery

                        The S&P 500 and Dow both hit new record highs yesterday, but are down marginally in today's pre-market.

                          CVS Health Beats on Q2 Earnings and Revenue Estimates

                          by Zacks Equity Research

                          CVS Health(CVS) rides high on Pharmacy Services segment in Q2.

                            Rite Aid Seems the Forbidden Fruit, Stock Down 20% in July

                            by Zacks Equity Research

                            Ever since Rite Aid Corp.'s (RAD) merger deal with Walgreens Boots Alliance Inc. (WBA) fell through on Jun 29, the stock has turned in to a forbidden fruit for investors.

                              Fred's Posts Dismal Comparable June Store Sales, Stock Down

                              by Zacks Equity Research

                              Fred's, (FRED), which has been struggling to recover from the blow of a failed merger between Rite Aid Corporation (RAD) and Walgreens Boots Alliance (WBA), recently announced soft June comparable store sales.

                                Fred's Stock Falls, Walgreens & Rite Aid Merger Deal Revised

                                by Zacks Equity Research

                                Fred's, Inc. (FRED) or Fred's Pharmacy lost over 20% yesterday after Walgreens Boots Alliance, Inc. (WBA) decided not to proceed with its planned takeover of the rival drugstore Rite Aid Corporation (RAD) due to various antitrust issues, as per Bloomberg. The cancelled merger significantly hurt Rite Aid???s stock too, which fell 26.46% yesterday.

                                  Have You Noticed Potential in Herbalife? Stock Adds 48% YTD

                                  by Zacks Equity Research

                                  Shares of Herbalife (HLF) have exhibited a bullish run on the index.

                                    What Will Rite Aid-Walgreens Merger Mean to Fred's (FRED)?

                                    by Zacks Equity Research

                                    Shares of Fred's (FRED) rallied nearly 23% on Jun 26 on rumors about the FTC approval of the acquisition of Rite Aid by Walgreens.

                                      CVS Health (CVS) Down 3.6% Since Earnings Report: Can It Rebound?

                                      by Zacks Equity Research

                                      CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                        Madeleine Johnson headshot

                                        Could Amazon Be the Next Big Pharmacy Giant?

                                        by Madeleine Johnson

                                        Amazon is reportedly looking to expand into new territory. According to CNBC, the e-commerce giant is trying to figure out how it can break into the multi-billion-dollar pharmacy industry.

                                          The Zacks Analyst Blog Highlights: MasterCard, CVS Health, Colgate-Palmolive, Charter Communications and Norfolk Southern

                                          by Zacks Equity Research

                                          The Zacks Analyst Blog Highlights: MasterCard, CVS Health, Colgate-Palmolive, Charter Communications and Norfolk Southern

                                            Mark Vickery headshot

                                            Top Research Reports for Today: MA, CVS, CL & More

                                            by Mark Vickery

                                            Today's Research Daily features new research reports on 16 major stocks, including MasterCard (MA), CVS Health (CVS) and Colgate-Palmolive (CL).

                                              CVS Health Beats on Q1 Earnings and Revenue Estimates

                                              by Zacks Equity Research

                                              Currently, CVS Health has a Zacks Rank #3 (Hold) but that could change following its first quarter 2017 earnings report which has just released.

                                                Rite Aid (RAD) Stock Up on Better-than-Expected Q4 Results

                                                by Zacks Equity Research

                                                Rite Aid (RAD) posted fourth-quarter fiscal 2017 results.

                                                  CVS Health Launches Reduced Rx for Affordable Medication

                                                  by Zacks Equity Research

                                                  CVS Health Corporation (CVS), a leading name in pharmacy benefit and retail pharmacy, recently announced the launch of a prescription savings program-Reduced Rx.